Drug Device Combination Products Market to Grow at 7.9% CAGR between 2013 and 2019

Albany – NY, Oct. 21, 2015 (GLOBE NEWSWIRE) — A recent study by Transparency Market Research (TMR) forecasts that the global drug device combination products market will grow at a CAGR of 7.9% between the years 2013 to 2019. TMR, a market intelligence firm based in the United States, in its report says that the global drug device combination products market which was valued at US$66 billion in 2012 will report a market value worth US$115 billion by 2019. The report is titled ‘Drug Device Combination Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019‘. 

Browse the full Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 report at http://www.transparencymarketresearch.com/drug-device-combination.html

The global drug device combination products market is primarily driven by factors like rising incidence of cardiovascular diseases, pain causing anomalies, colorectal cancer, diabetic retinopathy, asthma, prostate cancer, the problem of obesity, and a rapidly growing geriatric population. Drug device combination products basically refer to individual products that comprise two regulated components, which are a medical device and an active pharmaceutical ingredient that are either physically or chemically combined for producing one product. The drugs that are present within the device are either surface coated or impregnated. Due to their usefulness in the area of advanced medical care, combination products these days are considered to be highly innovative medical products. 

The global drug device combination products market is segmented on the basis of its various types, and geography. On the basis of types, the global drug device combination products market is classified into infusion pumps, drug eluting stents, orthopedic combination products, photosensitizers, inhalers, wound care combination products, transdermal patches, and other drug device combination products. Peripheral vascular stents and coronary stents are the two sub categories under the drug eluting stents category. The different types of infusion pumps are ambulatory infusion pumps and implantable infusion pumps. Orthopedic combination products include bone graft implants and antibiotic bone cement. The different types of inhalers dominating the global drug device combination products market are dry powder inhalers, nebulizers, and metered dose inhalers. The other drug device combination products include drug eluting beads and intraocular implants. Latest technologies like implants with drugs that promote lesser morbidity, pain relief, and faster healing are expected to drive the global drug device combination products market in the forthcoming years. 

From the regional perspective, the global drug device combination products market is dominated by North America in revenue terms. However, owing to rising incidence of diabetes, obesity, and cardiovascular diseases, the most lucrative market in the entire drug device combination products market is the Asia Pacific. The global drug device combination products market is expected to witness significant growth in the years to come owing to factors like rising demand for minimally invasive surgeries, NGO and government initiatives for promoting drug delivery implants, and increasing number of interventional cardiologists. A major growth restraint in this market is that of product recalls, due to adverse side effects to patients.

Get Market Research Sample Report: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1534

Some of the key players operating in the global drug device combination products market are W. L. Gore & Associates, Inc., Terumo Corporation, Stryker Corporation, Pinnacle Biologics, Inc., Mylan, Inc., Medtronic, Inc., Medline Industries, Inc., Ethicon, Inc., C.R. Bard, Inc., Covidien PLC, and CareFusion Corporation. 

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

CONTACT: Ms. Nachiket Ghumare
         State Tower,
         90 State Street,
         Suite 700,
         Albany NY - 12207
         United States
         USA - Canada Toll Free: 866-552-3453
         Email: sales@transparencymarketresearch.com
         Website: http://www.transparencymarketresearch.com/